Compounding Chemotherapy Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	150 Pages	Coherent Market Insights	June, 2023	CMI18049202

Best Price Guarantee
Price	from $4,500
Length	150 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049202

Compounding Chemotherapy Market, By Drug Type (Cytotoxic Drugs, Hormonal Agents, Immunomodulatory Agents, Targeted Therapies, Supportive Care Drugs), By Compounding Setting (Hospital Compounding, Compounding Pharmacies, Specialty Clinics, Homecare Settings), By Route of Administration (Intravenous (IV), Oral, Subcutaneous (SC), Intramuscular (IM), Intrathecal (IT)), By Patient Type (Adult Patients, Pediatric Patients, Geriatric Patients), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Leukemia, Lymphoma, Other specific cancer types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Compounding Method (Aseptic Compounding, Non-aseptic Compounding), By Packaging Type (Vials, Ampoules, Pre-filled Syringes, Bottles), By Regulatory Compliance (USP Chapter <797> Compliance, FDA Regulations, EMA Regulations), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Chemotherapy is a pharmacological therapy that targets the body's rapidly proliferating cells with a variety of potent poisons. It is mostly used to treat cancer as cancer cells proliferate and multiply significantly more quickly than the majority of bodily cells. In order to address the problem of medication error caused by a variety of factors, such as poor management of the communication between the doctor and the pharmacist, critical storage practices in pharmacies, and misunderstandings when using similar labels, the automatic method of compounding chemotherapy was introduced.

Market Dynamics:

Increasing prevalence of illnesses like cancer, bone marrow conditions, and immune system problems will continue to fuel growth of the global compounding chemotherapy market over the forecast period. Increasing costs for prescription drugs and changing payment policies are again expected to augment global compounding chemotherapy market growth over the forecast period. Rising consumer health benefits from the products will create new opportunities for the global compounding chemotherapy market. Hospitals and the healthcare industry are becoming more aware of compounded chemotherapy treatments or medicines, which is also assisting in the market's expansion.

The high cost of compounding chemotherapeutic products is expected to hamper growth of the global compounding chemotherapy market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global compounding chemotherapy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global compounding chemotherapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include B. Braun Melsungen AG, Fagron NV, PharMEDium Services, LLC (AmerisourceBergen Corporation), Baxter International Inc., Fresenius Kabi AG, Advanced Pharma, Inc., McGuff Compounding Pharmacy Services, Inc., Central Admixture Pharmacy Services, Inc. (CAPS), Institutional Pharmacy Solutions, LLC, Wedgewood Pharmacy, Medisca Inc., Dougherty's Holdings, Inc., PharMEDium Services, LLC (AmerisourceBergen Corporation), PharMEDium Services, LLC (AmerisourceBergen Corporation), BioScrip, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global compounding chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding chemotherapy market

Detailed Segmentation:

Global Compounding Chemotherapy Market, By Drug Type:

Cytotoxic Drugs

Hormonal Agents

Immunomodulatory Agents

Targeted Therapies

Supportive Care Drugs

Global Compounding Chemotherapy Market, By Compounding Setting:

Hospital Compounding

Compounding Pharmacies

Specialty Clinics

Homecare Settings

Global Compounding Chemotherapy Market, By Route of Administration:

Intravenous (IV)

Oral

Subcutaneous (SC)

Intramuscular (IM)

Intrathecal (IT)

Global Compounding Chemotherapy Market, By Patient Type:

Adult Patients

Pediatric Patients

Geriatric Patients

Global Compounding Chemotherapy Market, By Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Leukemia

Lymphoma

Other specific cancer types

Global Compounding Chemotherapy Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Compounding Chemotherapy Market, By Compounding Method:

Aseptic Compounding

Non-aseptic Compounding

Global Compounding Chemotherapy Market, By Packaging Type:

Vials

Ampoules

Pre-filled Syringes

Bottles

Global Compounding Chemotherapy Market, By Regulatory Compliance:

USP Chapter <797> Compliance

FDA Regulations

EMA Regulations

Global Compounding Chemotherapy Market, By Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Company Profile:

B. Braun Melsungen AG

Fagron NV

PharMEDium Services, LLC (AmerisourceBergen Corporation)

Baxter International Inc.

Fresenius Kabi AG

Advanced Pharma, Inc.

McGuff Compounding Pharmacy Services, Inc.

Central Admixture Pharmacy Services, Inc. (CAPS)

Institutional Pharmacy Solutions, LLC

Wedgewood Pharmacy

Medisca Inc.

Dougherty's Holdings, Inc.

PharMEDium Services, LLC (AmerisourceBergen Corporation)

PharMEDium Services, LLC (AmerisourceBergen Corporation)

BioScrip, Inc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Drug Type; Market Snapshot, By Compounding Setting; Market Snapshot, By Route of Administration; Market Snapshot, By Patient Type; Market Snapshot, By Cancer Type; Market Snapshot, By Distribution Channel; Market Snapshot, By Compounding Method; Market Snapshot, By Packaging Type; Market Snapshot, By Regulatory Compliance; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Increasing prevalence of illnesses like cancer, bone marrow conditions, and immune system problems; Increasing costs for prescription drugs and changing payment policies; Restraints; The High cost of compounding chemotherapeutic products; Opportunities; Rising consumer health benefits from the products; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Compounding Chemotherapy Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Compounding Chemotherapy Market , By Drug Type, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Cytotoxic Drugs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Hormonal Agents; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Immunomodulatory Agents; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Targeted Therapies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Supportive Care Drugs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Global Compounding Chemotherapy Market , By Compounding Setting, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Hospital Compounding; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Compounding Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Specialty Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Homecare Settings; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
7. Global Compounding Chemotherapy Market , By Route of Administration, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Intravenous (IV); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Oral; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Subcutaneous (SC); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Intramuscular (IM); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Intrathecal (IT); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Million)
8. Global Compounding Chemotherapy Market , By Patient Type, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Adult Patients; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Pediatric Patients; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Geriatric Patients; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
9. Global Compounding Chemotherapy Market , By Cancer Type, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Breast Cancer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Lung Cancer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Colorectal Cancer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Prostate Cancer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Leukemia; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Lymphoma; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Other specific cancer types; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); 10. Global Compounding Chemotherapy Market , By Distribution Channel, 2023-2030, (US$ Mn); Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); 11. Global Compounding Chemotherapy Market , By Compounding Method, 2023-2030, (US$ Mn); Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Aseptic Compounding; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Non-aseptic Compounding; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); 12. Global Compounding Chemotherapy Market , By Packaging Type, 2023-2030, (US$ Mn); Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Vials; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Ampoules; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Pre-filled Syringes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Bottles; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); 13. Global Compounding Chemotherapy Market , By Regulatory Compliance, 2023-2030, (US$ Mn); Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; USP Chapter <797> Compliance; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); FDA Regulations; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); EMA Regulations; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); 14. Global Compounding Chemotherapy Market , By Region, 2023-2030, (US$ Mn); Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2018–2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2023-2030,(US$ Mn); Europe; Asia Pacific; Latin America; Middle East & Africa; 15. Competitive Landscape; B.Braun Melsungen AG; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Fagron NV; PharMEDium Services, LLC (AmerisourceBergen Corporation); Baxter International Inc.; Fresenius Kabi AG; Advanced Pharma, Inc.; McGuff Compounding Pharmacy Services, Inc.; Central Admixture Pharmacy Services, Inc. (CAPS); Institutional Pharmacy Solutions, LLC; Wedgewood Pharmacy; Medisca Inc.; Dougherty's Holdings, Inc.; PharMEDium Services, LLC (AmerisourceBergen Corporation); PharMEDium Services, LLC (AmerisourceBergen Corporation); BioScrip, Inc.; Analyst Views; 16. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on “Global Compounding Chemotherapy Market” - Global forecast to 2030